ArthroSave raises new investment round to battle severe knee osteoarthritis

Patients with knee osteoarthritis have a damaged knee joint and suffer from persistent pain every day. In Europe alone over 2.2 million patients are affected by knee osteoarthritis and prevalence is rising dramatically, due to rising obesity rates and aging population.

Karianne Lindenhovius, CEO and co-founder of ArthroSave, explains: “ArthroSave has developed the KneeReviver enabling knee joint distraction as a joint preserving solution. Knee joint distraction with the KneeReviver is a temporary treatment that unloads the knee joint for six weeks. This results in relief of pain and improvement of function. Due to regeneration of the joint, the original knee joint will be preserved. This will postpone the knee replacement surgery for 10 more years and will prevent complex revision surgery later in life.”

#ArthroSave #Oost NL #Utrecht Holdings #osteoarthritis